Financial Architects, Inc Adma Biologics, Inc. Transaction History

Financial Architects, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$3.89 - $5.15 $75,855 - $100,425	-19,500 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$3.52 - $5.24 $3,520 - $5,240	1,000 Added 5.41%	19,500 $75,000
Q1 2019 May 13, 2019	BUY	$2.61 - $4.35 $48,285 - $80,475	18,500 New	18,500 $70,000
Q1 2019 May 03, 2019	SELL	$2.61 - $4.35 $48,285 - $80,475	-18,500 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$2.17 - $6.12 $7,595 - $21,420	3,500 Added 23.33%	18,500 $44,000
Q2 2018 Aug 03, 2018	BUY	$4.39 - $5.44 $65,850 - $81,600	15,000 New	15,000 $68,000

339

182M

1.72M

846K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.67B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.